Yuanxin Xu

Yuanxin brings more than 25 years of biotechnology and pharmaceutical experience to Intellia. As senior vice president, Early Development and Translational Medicine, she is responsible for pharmacology, toxicology, drug metabolism ancd pharmacokinetics, as well as bioanalysis. Prior to joining Intellia, Yuanxin spent five years at Alnylam, where she led bioanalytical sciences for RNAi development to support preclinical and clinical programs. Prior to Alnylam, she spent 13 years at Sanofi most recently serving as senior scientific director. While there, she supported clinical studies on biologics, antibodies, small molecules, as well as cell and gene therapies. Yuanxin received her B.M. from Peking University Health Science and her Ph.D. in Biochemistry from lowa State University. She also holds a certificate in Organizational Leadership from Harvard Publishing.